๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

9 recruiting trials

for Advanced Or Metastatic Merkel Cell Carcinoma

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors NCT05592626Phase 1, Phase 219 sites๐Ÿ“ Sacramento๐Ÿ“ Celebration๐Ÿ“ Miami Marengo Therapeutics, Inc. ยท Tests: STAR0602, Irinotecan (Camptosar), Docetaxel (Taxotere) French National Database of Rare Dermatological Cancers NCT03210935n/a34 sites๐Ÿ“ Dijon๐Ÿ“ Le Mans๐Ÿ“ Pierre-Bรฉnite University Hospital, Lille Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rฮฑ Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer NCT05267626Phase 1, Phase 217 sites๐Ÿ“ Miami๐Ÿ“ Grand Rapids๐Ÿ“ Minneapolis Aulos Bioscience, Inc. ยท Tests: AU-007, Aldesleukin, Avelumab, Nivolumab Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors NCT05269381Phase 1, Phase 21 site๐Ÿ“ Jacksonville Mayo Clinic ยท Tests: Cyclophosphamide, Neoantigen Peptide Vaccine, Pembrolizumab, Sargramostim, Biospecimen Collection A Beta-only IL-2 ImmunoTherapY Study NCT05086692Phase 1, Phase 228 sites๐Ÿ“ San Diego๐Ÿ“ San Francisco๐Ÿ“ Santa Monica Medicenna Therapeutics, Inc. ยท Tests: MDNA11, Pembrolizumab (KEYTRUDAยฎ) Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors NCT07080242Phase 124 sites๐Ÿ“ Huntsville๐Ÿ“ Glendale๐Ÿ“ Long Beach SystImmune Inc. ยท Tests: BL-M14D1 IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC) NCT06940440Phase 12 sites๐Ÿ“ Tampa๐Ÿ“ Madison TuHURA Biosciences, Inc. ยท Tests: IFx-Hu2.0, Pembrolizumab A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors NCT07115043Phase 1, Phase 213 sites๐Ÿ“ Grand Rapids๐Ÿ“ St Louis๐Ÿ“ Pittsburgh AstraZeneca ยท Tests: AZD6750, rilvegostomig Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naรฏve Participants With Advanced Or Metastatic Merkel Cell Carcinoma NCT06947928Phase 2, Phase 318 sites๐Ÿ“ Los Angeles๐Ÿ“ San Francisco๐Ÿ“ Stanford TuHURA Biosciences, Inc. ยท Tests: IFx-Hu2.0, Placebo, Pembrolizumab
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy